Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Reported today (16 July 2018) in the journal Nature Biotechnology, the study also revealed that standard tests for detecting DNA changes miss finding this genetic damage, and that caution and specific testing will be required for any potential gene therapies.
CRISPR/Cas9 is one of the newest genome editing tools. It can alter sections of DNA in cells by cutting at specific points and introducing changes at that location. Already extensively used in scientific research, CRISPR/Cas9 has also been seen as a promising way to create potential genome editing treatments for diseases such as HIV, cancer or sickle cell disease. Such therapeutics could inactivate a disease-causing gene, or correct a genetic mutation. However, any potential treatments would have to prove that they were safe.
Previous research had not shown many unforeseen mutations from CRISPR/Cas9 in the DNA at the genome editing target site. To investigate this further the researchers carried out a full systematic study in both mouse and human cells and discovered that CRISPR/Cas9 frequently caused extensive mutations, but at a greater distance from the target site.
The researchers found many of the cells had large genetic rearrangements such as DNA deletions and insertions. These could lead to important genes being switched on or off, which could have major implications for CRISPR/Cas9 use in therapies. In addition, some of these changes were too far away from the target site to be seen with standard genotyping methods.
“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells, and we found that changes in the DNA have been seriously underestimated before now. It is important that anyone thinking of using this technology for gene therapy proceeds with caution, and looks very carefully to check for possible harmful effects.”
Professor Allan Bradley, corresponding author on the study from the Wellcome Sanger Institute
“My initial experiment used CRISPR/Cas9 as a tool to study gene activity, however it became clear that something unexpected was happening. Once we realised the extent of the genetic rearrangements we studied it systematically, looking at different genes and different therapeutically relevant cell lines, and showed that the CRISPR/Cas9 effects held true.”
Michael Kosicki, the first author from the Wellcome Sanger Institute
The work has implications for how CRISPR/Cas9 is used therapeutically and is likely to re-spark researchers’ interest in finding alternatives to the standard CRISPR/Cas9 method for gene editing.
“This study is the first to assess the repertoire of genomic damage arising at a CRISPR/Cas9 cleavage site. While it is not known if genomic sites in other cell lines will be affected in the same way, this study shows that further research and specific testing is needed before CRISPR/Cas9 is used clinically.”
Professor Maria Jasin, an independent researcher from Memorial Slone Kettering Cancer Centre, New York, who was not involved in the study
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Scientists treat first US patients with gene-edited cells on April 17, 2019 at 10:41 am
CRISPR-cas9, the powerful gene-editing tool, has been getting a bad reputation lately following last year’s shocking news of Chinese twins born with altered genomes. But done diligently and ethically, ... […]
- CRISPR Screens Identify New Glioblastoma Targets and Resistance Genes on April 17, 2019 at 7:00 am
Scientists in Canada have used CRISPR-Cas9 technology to identify potential new targets for glioblastoma (GBM), the most common type of primary brain tumor in adults. The approach used genome editing ... […]
- CRISPR can turn human cells into biocomputers on April 16, 2019 at 4:15 pm
Researchers have integrated two CRISPR-Cas9-based core processors into human cells, a step towards creating powerful biocomputers. Controlling gene expression through gene switches based on a model ... […]
- First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway on April 16, 2019 at 10:20 am
The powerful gene-editing technique called CRISPR has been in the news a lot. And not all the news has been good: A Chinese scientist stunned the world last year when he announced he had used CRISPR ... […]
- Engineering ‘Hairpins’ Increases CRISPR Accuracy on April 16, 2019 at 6:35 am
“But the solutions proposed thus far cannot be easily translated between different CRISPR systems.” CRISPR/Cas9 is a defense system that bacteria use to target and cleave the DNA of invading viruses. ... […]
- CRISPR-Cas3 Innovation Holds Promise for Disease Cures, Advancing Science on April 16, 2019 at 6:31 am
The new system, called CRISPR-Cas3, can efficiently erase long stretches of DNA from a targeted site in the human genome, a capability not easily attainable in more traditional CRISPR-Cas9 systems. ... […]
- CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia on April 16, 2019 at 5:00 am
In February 2019, CRISPR Therapeutics and Vertex announced that the first patient had been treated with CTX001 in a Phase 1/2 clinical study of patients with TDT, marking the first company-sponsored ... […]
- A biosynthetic dual-core cell computer on April 16, 2019 at 4:52 am
ETH researchers have integrated two CRISPR-Cas9-based core processors into human cells. This represents a huge step towards creating powerful biocomputers. Controlling gene expression through gene ... […]
- A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system on April 10, 2019 at 2:09 am
Therapies that target the function of immune cells have significant clinical efficacy in diseases such as cancer and autoimmunity. Although functional genomics has accelerated therapeutic target ... […]
via Bing News